Recent Advances in the Diagnosis and Treatment of Neophilia

Recent Advances in the Diagnosis and Treatment of Neophilia

The conventional wisdom is that the sick care, higher education and government establishments are resistant to change. Not true, says theoretical physicist, Leonard Mlodinow, who believes human beings have the unique ability to think flexibly in ways that would unleash an inherent creativity — a skill he calls elastic thinking. In fact, says Mlodinow, human resist negative change but embrace positive change. He claims we are all neophiliacs by nature.

But, for entrepreneurs and intrapreneurs, embracing change and advocating for it can be hazardous to your career. Beware of these landmines:

  1. When to ask for forgiveness instead of permission.
  2. When and how to tell truth to authority
  3. How to bridge the now with the next and the new
  4. How to bridge strategy with execution
  5. When to pull the plug
  6. When to take the white coat and shove it
  7. Being a disruptive intra/entrepreneur v being a disruptive physician
  8. Working in a top down hierarchy v one that is bottom up
  9. Practicing strategic thinking v strategic planning
  10. Thinking you are leading when you are just managing

Embracing change opens doors. You'll know you are innovating when you start making enemies. If you are unsure, download this neophiliapp.

Just realize that the treatments for chronic neophilia are often ineffective and limited.

Arlen Meyers, MD, MBA is the President and CEO of the Society of Physician Entrepreneurs

Share this article

Leave your comments

Post comment as a guest

terms and condition.
  • Kumar Mohit

    Good article

  • Oliver Smith

    Interesting piece

Share this article

Arlen Meyers, MD, MBA

Former Contributor

Arlen Meyers, MD, MBA is a professor emeritus of otolaryngology, dentistry, and engineering at the University of Colorado School of Medicine and the Colorado School of Public Health and President and CEO of the Society of Physician Entrepreneurs at He has created several medical device and digital health companies. His primary research centers around biomedical and health innovation and entrepreneurship and life science technology commercialization. He consults for and speaks to companies, governments, colleges and universities around the world who need his expertise and contacts in the areas of bio entrepreneurship, bioscience, healthcare, healthcare IT, medical tourism -- nationally and internationally, new product development, product design, and financing new ventures. He is a former Harvard-Macy fellow and In 2010, he completed a Fulbright at Kings Business, the commercialization office of technology transfer at Kings College in London. He recently published "Building the Case for Biotechnology." "Optical Detection of Cancer", and " The Life Science Innovation Roadmap". He is also an associate editor of the Journal of Commercial Biotechnology and Technology Transfer and Entrepreneurship and Editor-in-Chief of Medscape. In addition, He is a faculty member at the University of Colorado Denver Graduate School where he teaches Biomedical Entrepreneurship and is an iCorps participant, trainer and industry mentor. He is the Chief Medical Officer at and and Chairman of the Board at GlobalMindED at, a non-profit at risk student success network. He is honored to be named by Modern Healthcare as one of the 50 Most Influential Physician Executives of 2011 and nominated in 2012 and Best Doctors 2013.

Cookies user prefences
We use cookies to ensure you to get the best experience on our website. If you decline the use of cookies, this website may not function as expected.
Accept all
Decline all
Read more
Tools used to analyze the data to measure the effectiveness of a website and to understand how it works.
Google Analytics